{
  "trial_id": "NCT00120289",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Men and women aged 45 and older with established vascular disease and atherogenic dyslipidemia",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "dyslipidemia",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Established vascular disease defined as one or more of the following: (1) documented coronary artery disease (CAD); (2) documented cerebrovascular or carotid disease; (3) documented symptomatic peripheral arterial disease (PAD)",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Atherogenic dyslipidemia defined as: (1) LDL-C of less than or equal to 160 mg/dL (4.1 mmol/L); (2) HDL-C of less than or equal to 40 mg/dL (1.0 mmol/L) for men or less than or equal to 50 mg/dL (1.3 mmol/L) for women; (3) TG greater than or equal to 150 mg/dL (1.7 mmol/L) and less than or equal to 400 mg/dL (4.5 mmol/L)",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "For patients entering the trial on a statin: (1) the upper limit for LDL-C is adjusted according to the specific statin and statin dose; (2) HDL-C of less than or equal to 42 mg/dL (1.1 mmol/L) for men or less than or equal to 53 mg/dL (1.4 mmol/L) for women; (3) TG greater than or equal to 125 mg/dL (1.4 mmol/L) and less than or equal to 400 mg/DL (4.5 mmol/L)",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "Coronary artery bypass graft (CABG) surgery within 1 year of planned enrollment",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Percutaneous coronary intervention (PCI) within 4 weeks of planned enrollment",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Hospitalization for acute coronary syndrome and discharge within 4 weeks of planned enrollment",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Fasting glucose greater than 180 mg/dL (10 mmol/L) or hemoglobin A1C greater than 9%",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "For patients with diabetes, inability or refusal to use a glucometer for home monitoring of blood glucose",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "The patient has type 1 diabetes and cardiomyopathy. He is being treated with ACE inhibitors and Beta blockers.",
  "_meta": {
    "topic_id": "65",
    "trial_id": "NCT00120289",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}